drugset
drugset / Trial / NCT03259490

This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills. The Study is Done in Healthy Men and Women and Measures the Amount of Each Medicine in the Blood

NCT03259490 ↗

Phase 1 Completed 30 enrolled Boehringer Ingelheim Eli Lilly and Company · collab
RandomizedCrossoverOpen-labelTreatment

Summary

To establish the bioequivalence of one fixed dose combination (FDC) tablet of empagliflozin/linagliptin/metformin extended release (XR) versus the free combination of empagliflozin tablet, linagliptin tablet, and metformin XR tablets administered as a single dose under fed conditions

Timeline

Start
2017-08-31
Primary completion
2017-11-13
Completion
2017-11-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Empagliflozin Small molecule — Oral
Subject Empagliflozin/linagliptin/metformin HCl Unknown — Oral
Subject Linagliptin Small molecule — Oral
Subject Metformin Small molecule — Oral

Indications

No indication recorded.